Drug details

Cerdelga (eiglustat capsules)

type of Metabolic & Endocrine, Other

Cerdelga (eliglustat) is a small molecule inhibitor of glucosylceramide synthase used for the long-term treatment of adult patients with Gaucher disease type 1 (GD1) who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.

This drug may have the following side effects:

• itching
• rash, and
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• fainting, 
• fast or irregular heartbeat, 
• severe dizziness, 

The following drugs are related to Cerdelga, either as a replacement or used together:

• Ceredase (alglucerase injection)
• Cerezyme (imiglucerase)
• Elelyso (taliglucerase alfa)
• Zavesca (miglustat)
• VPRIV (velaglucerase alfa for injection)